{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:31:16Z","timestamp":1775266276950,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T00:00:00Z","timestamp":1532131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.nefro.2018.05.007","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T09:23:25Z","timestamp":1541669005000},"page":"579-586","source":"Crossref","is-referenced-by-count":16,"title":["Calcifilaxis en pacientes con enfermedad renal cr\u00f3nica: una enfermedad todav\u00eda desconcertante y potencialmente mortal"],"prefix":"10.1016","volume":"38","author":[{"given":"David","family":"Cucchiari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose-Vicente","family":"Torregrosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2018.05.007_bib0215","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2215\/CJN.00530108","article-title":"Calciphylaxis from nonuremic causes: A systematic review","volume":"3","author":"Nigwekar","year":"2008","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2018.05.007_bib0220","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archdermatol.2009.103","article-title":"Calciphylaxis associated with chronic inflammatory conditions, immunosuppression therapy, and normal renal function: A report of 2 cases","volume":"145","author":"Swanson","year":"2009","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.nefro.2018.05.007_bib0225","first-page":"501","article-title":"Calciphylaxis: Beyond CKD-MBD","volume":"37","author":"Fernandez","year":"2017","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefro.2018.05.007_bib0230","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/ndt\/gfw025","article-title":"Lack of evidence does not justify neglect: How can we address unmet medical needs in calciphylaxis?","volume":"31","author":"Brandenburg","year":"2016","journal-title":"Nephrol Dial Transplant."},{"issue":"Suppl 3","key":"10.1016\/j.nefro.2018.05.007_bib0235","doi-asserted-by":"crossref","first-page":"S724","DOI":"10.1007\/s11606-014-2910-1","article-title":"Quantifying a rare disease in administrative data: The example of calciphylaxis","volume":"29","author":"Nigwekar","year":"2014","journal-title":"J Gen Intern Med."},{"key":"10.1016\/j.nefro.2018.05.007_bib0240","doi-asserted-by":"crossref","unstructured":"Nigwekar SU, Zhao S, Wenger J, Hymes JL, Maddux FW, Thadhani RI, et al. A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors. J Am Soc Nephrol 2016;27:3421-29.","DOI":"10.1681\/ASN.2015091065"},{"key":"10.1016\/j.nefro.2018.05.007_bib0245","doi-asserted-by":"crossref","unstructured":"Brandenburg VM, Kramann R, Rothe H, Kaesler N, Korbiel J, Specht P, et al. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry. Nephrol Dial Transplant. 2017;32:126-32.","DOI":"10.1093\/ndt\/gfv438"},{"key":"10.1016\/j.nefro.2018.05.007_bib0250","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2147\/IJNRD.S115701","article-title":"Calciphylaxis in peritoneal dialysis patients: A single center cohort study","volume":"9","author":"Zhang","year":"2016","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.nefro.2018.05.007_bib0255","doi-asserted-by":"crossref","unstructured":"McCarthy JT, El-Azhary RA, Patzelt MT, Weaver AL, Albright RC, Bridges AD, et al. Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis. Mayo Clin Proc. 2016;91:1384-94.","DOI":"10.1016\/j.mayocp.2016.06.025"},{"key":"10.1016\/j.nefro.2018.05.007_bib0260","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4161\/oxim.3.2.11354","article-title":"Calcific uremic arteriolopathy: Pathophysiology, reactive oxygen species and therapeutic approaches","volume":"3","author":"Sowers","year":"2010","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.nefro.2018.05.007_bib0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ajkd.2015.01.034","article-title":"Calciphylaxis: Risk factors, diagnosis, and treatment","volume":"66","author":"Nigwekar","year":"2015","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2018.05.007_bib0270","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000326903","article-title":"Vitamin D and vascular calcification in chronic kidney disease","volume":"34","author":"Rodriguez","year":"2011","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.nefro.2018.05.007_bib0275","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2018.05.007_bib0280","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.nefro.2018.05.007_bib0285","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaad.2007.12.006","article-title":"Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B","volume":"58","author":"Weenig","year":"2008","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.nefro.2018.05.007_bib0290","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00774-013-0430-4","article-title":"Cyclic variations of bone resorption mediators and markers in the different phases of the menstrual cycle","volume":"31","author":"Mozzanega","year":"2013","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.nefro.2018.05.007_bib0295","doi-asserted-by":"crossref","unstructured":"Helas S, Goettsch C, Schoppet M, Zeitz U, Hempel U, Morawietz H, et al. Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol. 2009;175:473-8.","DOI":"10.2353\/ajpath.2009.080957"},{"key":"10.1016\/j.nefro.2018.05.007_bib0300","doi-asserted-by":"crossref","unstructured":"Samelson EJ, Miller PD, Christiansen C, Daizadeh NS, Grazette L, Anthony MS, et al. RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk. J Bone Miner Res. 2014;29:450-7.","DOI":"10.1002\/jbmr.2043"},{"key":"10.1016\/j.nefro.2018.05.007_bib0305","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S8756-3282(02)00821-9","article-title":"Matrix Gla protein binding to hydroxyapatite is dependent on the ionic environment: Calcium enhances binding affinity but phosphate and magnesium decrease affinity","volume":"31","author":"Roy","year":"2002","journal-title":"Bone."},{"key":"10.1016\/j.nefro.2018.05.007_bib0310","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2215\/CJN.00770208","article-title":"Vitamin K-dependent proteins, warfarin, and vascular calcification","volume":"3","author":"Danziger","year":"2008","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2018.05.007_bib0315","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/ndt\/gfr658","article-title":"A case-control study of calciphylaxis in Japanese end-stage renal disease patients","volume":"27","author":"Hayashi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2018.05.007_bib0320","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1681\/ASN.2016060651","article-title":"Vitamin K-dependent carboxylation of matrix Gla protein influences the risk of calciphylaxis","volume":"28","author":"Nigwekar","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2018.05.007_bib0325","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaad.2009.12.007","article-title":"Possible role of hypercoagulability in calciphylaxis: Review of the literature","volume":"64","author":"Harris","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.nefro.2018.05.007_bib0330","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jamadermatol.2017.4920","article-title":"Association between hypercoagulable conditions and calciphylaxis in patients with renal disease: A case-control study","volume":"154","author":"Dobry","year":"2018","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.nefro.2018.05.007_bib0335","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1046\/j.1523-1755.2002.00375.x","article-title":"Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy","volume":"61","author":"Fine","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2018.05.007_bib0340","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s10157-013-0782-z","article-title":"Calciphylaxis: Diagnosis and clinical features","volume":"17","author":"Hayashi","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.nefro.2018.05.007_bib0345","first-page":"66","article-title":"Calciphylaxis: A review","volume":"2","author":"Magro","year":"2011","journal-title":"J Am Col Certif Wound Spec."},{"key":"10.1016\/j.nefro.2018.05.007_bib0350","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.jaad.2012.05.037","article-title":"Net-like pattern of calcification on plain soft-tissue radiographs in patients with calciphylaxis","volume":"67","author":"Shmidt","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.nefro.2018.05.007_bib0355","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/jamadermatol.2015.4591","article-title":"The role of bone scintigraphy in the diagnosis of calciphylaxis","volume":"153","author":"Paul","year":"2017","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.nefro.2018.05.007_bib0360","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1111\/ijd.13043","article-title":"Calciphylaxis: A case series and the role of radiology in diagnosis","volume":"55","author":"Bonchak","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.nefro.2018.05.007_bib0365","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/j.ajkd.2006.05.031","article-title":"A case report comparing various radiological tests in the diagnosis of calcific uremic arteriolopathy","volume":"48","author":"Bleibel","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2018.05.007_bib0370","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaad.2006.08.065","article-title":"Calciphylaxis: Natural history, risk factor analysis, and outcome","volume":"56","author":"Weening","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.nefro.2018.05.007_bib0375","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijid.2014.03.1397","article-title":"A systematic review of maggot debridement therapy for chronically infected wounds and ulcers","volume":"25","author":"Sun","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.nefro.2018.05.007_bib0380","first-page":"559","article-title":"Sterile maggots like coadjuvanted at the local treatment in a patients with proximal calciphylaxis","volume":"25","author":"Picazo","year":"2005","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefro.2018.05.007_bib0385","doi-asserted-by":"crossref","unstructured":"Polizzotto MN, Bryan T, Ashby MA, Martin P. Symptomatic management of calciphylaxis: a case series and review of the literature. J Pain Symptom Manage. 2006;32:186-90.","DOI":"10.1016\/j.jpainsymman.2006.03.009"},{"key":"10.1016\/j.nefro.2018.05.007_bib0390","first-page":"676","article-title":"Hyperbaric oxygen therapy for calcific uremic arteriolopathy: A case series","volume":"15","author":"Basile","year":"2002","journal-title":"J Nephrol"},{"key":"10.1016\/j.nefro.2018.05.007_bib0395","unstructured":"Torregrosa JV, Bover J, Cannata And\u00eda J, Lorenzo V, de Francisco AL, et al. Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.). Nefrologia. 2011;31 Suppl 1:3-32."},{"key":"10.1016\/j.nefro.2018.05.007_bib0400","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2215\/CJN.10221014","article-title":"The effect of cinacalcet on calcific uremic arteriolopathy events in patients receiving hemodialysis: The EVOLVE trial","volume":"10","author":"Floege","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2018.05.007_bib0405","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1161\/STROKEAHA.113.001701","article-title":"Preventing stroke in patients with chronic kidney disease and atrial fibrillation: Benefit and risks of old and new oral anticoagulants","volume":"44","author":"Reinecke","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.nefro.2018.05.007_bib0410","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2215\/CJN.09880912","article-title":"Sodium thiosulfate therapy for calcific uremic arteriolopathy","volume":"8","author":"Nigwekar","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2018.05.007_bib0415","first-page":"231","article-title":"Clinical management of calcific uremic arteriolopathy before and after therapeutic inclusion of bisphosphonates","volume":"83","author":"Torregrosa","year":"2015","journal-title":"Clin Nephrol."},{"key":"10.1016\/j.nefro.2018.05.007_bib0420","doi-asserted-by":"crossref","unstructured":"Brandenburg V, Sinha S, Torregrosa JV, Salcedo C, Klassen P, Garg R, et al. Phase 2 open label single arm repeat dose study to assess the effect of SNF472 on wound healing in uraemic calciphylaxis patients. J Am Soc Nephrol. 2017;28. Abstract Supplement: 303.","DOI":"10.1093\/ndt\/gfy104.FO020"}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699518301085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699518301085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:27:18Z","timestamp":1775262438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699518301085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0211699518301085"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2018.05.007","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}